Consonance Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-142,943
| Closed | -$10.4M | – | 37 |
|
|
2019
Q3 | $10.4M | Hold |
142,943
| – | – | 1.03% | 23 |
|
|
2019
Q2 | $11.8M | Hold |
142,943
| – | – | 0.83% | 25 |
|
|
2019
Q1 | $10.1M | Hold |
142,943
| – | – | 0.64% | 24 |
|
|
2018
Q4 | $6.44M | Hold |
142,943
| – | – | 0.47% | 23 |
|
|
2018
Q3 | $8.08M | Hold |
142,943
| – | – | 0.44% | 29 |
|
|
2018
Q2 | $9.55M | Hold |
142,943
| – | – | 0.62% | 28 |
|
|
2018
Q1 | $8.32M | Sell |
142,943
-35
| -0% | -$2.04K | 0.76% | 23 |
|
|
2017
Q4 | $9.22M | Sell |
142,978
-25
| -0% | -$1.61K | 0.83% | 20 |
|
|
2017
Q3 | $7.51M | Hold |
143,003
| – | – | 0.83% | 16 |
|
|
2017
Q2 | $6.69M | Hold |
143,003
| – | – | 0.79% | 16 |
|
|
2017
Q1 | $7.08M | Sell |
143,003
-348,605
| -71% | -$17.3M | 0.74% | 20 |
|
|
2016
Q4 | $29.8M | Sell |
491,608
-161,650
| -25% | -$9.8M | 3.27% | 14 |
|
|
2016
Q3 | $43.3M | Sell |
653,258
-164,198
| -20% | -$10.9M | 4.17% | 11 |
|
|
2016
Q2 | $45.6M | Sell |
817,456
-210,908
| -21% | -$11.8M | 6.46% | 7 |
|
|
2016
Q1 | $34.6M | Buy |
1,028,364
+81,875
| +9% | +$2.76M | 5.24% | 12 |
|
|
2015
Q4 | $42.7M | Sell |
946,489
-109,800
| -10% | -$4.95M | 5.73% | 10 |
|
|
2015
Q3 | $41.7M | Buy |
1,056,289
+498
| +0% | +$19.7K | 5.87% | 7 |
|
|
2015
Q2 | $65.5M | Sell |
1,055,791
-68,876
| -6% | -$4.27M | 6.58% | 7 |
|
|
2015
Q1 | $70.3M | Buy |
1,124,667
+34,600
| +3% | +$2.16M | 6.41% | 7 |
|
|
2014
Q4 | $61.5M | Buy |
1,090,067
+540,240
| +98% | +$30.5M | 7.92% | 4 |
|
|
2014
Q3 | $15.5M | Buy |
549,827
+194,551
| +55% | +$5.5M | 2.13% | 16 |
|
|
2014
Q2 | $12.2M | Buy |
355,276
+104,013
| +41% | +$3.58M | 1.82% | 21 |
|
|
2014
Q1 | $7.88M | Buy |
+251,263
| New | +$7.88M | 1.17% | 24 |
|